40164_2019_141_MOESM1_ESM.docx (89.31 kB)

MOESM1 of Ibrutinib inhibits antibody dependent cellular cytotoxicity induced by rituximab or obinutuzumab in MCL cell lines, not overcome by addition of lenalidomide

Download (89.31 kB)